Stay updated with breaking news from Phio Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marlborough biopharma Phio Pharmaceuticals is ushering in a new strategic plan seeking to reposition the company from pure discovery research to full development, utilizing clinical trials.
Equities analysts expect Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Rating) to report ($0.31) earnings per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Phio Pharmaceuticals’ earnings. Phio Pharmaceuticals posted earnings of ($0.20) per share during the same quarter last year, which suggests a negative year over year growth rate […]
Wall Street brokerages expect that Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Rating) will post earnings per share of ($0.30) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Phio Pharmaceuticals’ earnings. Phio Pharmaceuticals reported earnings per share of ($0.32) in the same quarter last year, which suggests a positive year over […]